| Date | Title | Description |
| 29.06.2026 | Andera Partners joins the European Life Sciences Coalition (ELSC) with the aim to support the mobilization of capital for life sciences innovation in Europe. | Andera Partners joins the European Life Sciences Coalition (ELSC), alongside Forbion, HealthCap, Novo Holdings, Omega Funds, Sofinnova Partners, Van Lanschot Kempen, VIB, BioInnovation Institute, 4BIO Capital, Cooley and Covington.
Launched... |
| 22.10.2025 | EQT Life Sciences’ ImCheck Therapeutics to be acquired by Ipsen in a transaction valued at up to EUR 1 billion | EQT Life Sciences’ ImCheck Therapeutics to be acquired by Ipsen in a transaction valued at up to EUR 1 billion
Wed, Oct 22, 2025 09:20 CET Report this content
Ipsen and ImCheck Therapeutics have entered into a definitive share purchase agre... |
| 26.04.2025 | Granite Bio: A New Force in Immunology with $100 Million Backing | Granite Bio has burst onto the scene, armed with $100 million in funding. This clinical-stage immunology company is not just another player; it’s a potential game-changer. With a focus on autoimmune diseases, Granite Bio is targeting the ro... |
| 25.04.2025 | Granite Bio: Immunology Company Debuts With $100 Million In Funding | Granite Bio, a clinical-stage immunology company, announced it has emerged from stealth with $100 million in funding. This includes a $30 million Series A led by founding investors Versant Ventures and Novartis Venture Fund and a $70 millio... |
| 10.10.2024 | Kurma Partners: First Closing Of €250 Million Biofund IV | Kurma Partners, an asset manager focused on improving human health, announced that it has raised EUR 140 million, completing the first closing of Biofund IV. By the final closing in 2025, Kurma aims to have raised a total of €250 million in... |
| 18.09.2024 | Brenus Pharma: A New Dawn in Cancer Vaccines | In the world of biotechnology, every breakthrough is a beacon of hope. Brenus Pharma, a Lyon-based biotech company, has recently raised €22.2 million (approximately $25 million) in a Series A funding round. This infusion of capital is not j... |
| 18.09.2024 | Lyon-based Brenus Pharma raises €22.2 million for precision cancer vaccines | Brenus Pharma, a French biotech company specializing in the development of cancer vaccines, announced the completion of a €22.2 million Series A financing round. The round is led by Angelor, an investment fund bringing together a cluster of... |
| 15.07.2024 | Andera Partners’ portfolio company Amolyt Pharma completes acquisition by AstraZeneca | Andera Partners, a leading European private equity player, announced today that its portfolio company Amolyt Pharma, a global, clinical-stage biopharmaceutical company specializing in developing therapeutic peptides for rare endocrine and r... |
| 15.07.2024 | AstraZeneca Closes Acquisition of Amolyt Pharma | Amolyt Pharma, an Ecully, France global, clinical-stage biopharmaceutical company specializing in developing therapeutic peptides for rare endocrine and related diseases, announced that its previously announced acquisition by global pharmac... |
| 25.04.2024 | 1st Quarter Results | 1st Quarter Results
Thu, Apr 25, 2024 08:00 CET Report this content
AstraZeneca
25 April 2024
Q1 2024 results
Very strong revenue and EPS growth in the first quarter coupled with exciting pipeline delivery
Revenue and EPS summary
Q1 2024 % ... |
| 26.03.2024 | 10 French startups to watch in 2024 | In 2023 French companies raised €8.4 billion over 410 deals. According to our Annual report, France took third place among countries by the total raised amount.
The companies within the energy sector contributed the most to the numbers, wit... |
| 18.03.2024 | AstraZeneca to acquire Amolyt Pharma, expanding late-stage rare disease pipeline | Amolyt development portfolio includes Phase III asset with potential to address significant unmet need in patients with chronic hypoparathyroidism
Acquisition to further expand the Alexion, AstraZeneca Rare Disease pipeline beyond complemen... |
| 14.03.2024 | Amolyt Pharma, an Andera Partners’ portfolio company, announces its sale to AstraZeneca | Amolyt Pharma, a global, clinical-stage biopharmaceutical company specializing in developing therapeutic peptides for rare endocrine and related diseases, today announced it has entered into a definitive agreement for AstraZeneca to acquire... |
| 12.01.2023 | French pharma Amolyt nets €130 million series C co-led by Sofinnova Partners | Amolyt Pharma, an Ecully, France-based pharma startup working on rare disease treatments, has closed a €130 million series C round.
Amolyt is targeting rare indications affecting the body's hormone supply from endocrine glands. The series C... |
| 09.01.2023 | Amolyt Pharma Raises $138M in Series C Financing | Amolyt Pharma, a Lyon, France-based company specialized in developing therapeutic peptides for rare endocrine and related diseases, raised $138M in Series C funding.
The round was co-led by Sofinnova Partners and Intermediate Capital Group,... |
| 20.09.2021 | Amolyt Pharma Raises $80M in Series B Financing | Amolyt Pharma, a Lyon, France and Cambridge, Mass.-based company specialized in developing therapeutic peptides for rare endocrine and related diseases, closed an $80m Series B equity financing round.
The round was co-led by Sectoral Asset ... |
| 20.09.2021 | Digital health news, funding roundup in the prior week; September 20 | Biden administration seeks to expand telehealth; BetterUp acquires Motive and Impraise
Biden administration seeks to expand telehealth in rural America. New funding will allow more medical appointments to take place via video in rural commu... |
| 18.09.2021 | Daily funding roundup - September 18th, 2021 | Francis Medical raised $55M; CodeSignal landed $50M; Ketch secured $23M; Roboflow picks up $20M
Whatnot: Whatnot is a L.A.-based startup that hosts live-streamed video sales and auctions of Pokemon cards and other collectibles. Whatnot has ... |
| 17.09.2021 | Daily funding roundup - September 17th, 2021 | Francis Medical raised $55M; CodeSignal landed $50M; Ketch secured $23M; Roboflow picks up $20M
Whatnot: Whatnot is a L.A.-based startup that hosts live-streamed video sales and auctions of Pokemon cards and other collectibles. Whatnot has ... |
| 16.09.2021 | Novo-backed Amolyt Pharma snags $80M series B for endocrine pipeline | Amolyt Pharma has secured $80 million in financing from the likes of Novo Holdings and comes just a week after moving forward with a PeptiDream collaboration.
The Lyon, France-based biotech picked up the series B financing on Thursday to br... |
| 16.09.2021 | Novo-backed Amolyt Pharma snags $80M series B for endocrine pipeline
Complimentary Virtual Event | Amolyt Pharma has secured $80 million in financing from the likes of Novo Holdings and comes just a week after moving forward with a PeptiDream collaboration.
Proceeds could also bankroll potential in-licensing programs, Amolyt said. The bi... |
| 16.09.2021 | Amolyt Pharma Announces $80 Million Series B Financing led by Sectoral Asset Management and Andera Partners | LYON, France and CAMBRIDGE, Mass., Sept. 16, 2021 (GLOBE NEWSWIRE) -- Amolyt Pharma, a global company specialized in developing therapeutic peptides for rare endocrine and related diseases, today announced that the company has closed an $80... |
| - | Exclusive: The Founder Mental Health Pledge is looking to create a turning point in startup culture | Economic crises are human crises. And yet, even in the worst of times, we still struggle to talk about mental health.
Last year, as Silicon Valley Bank was collapsing, Naveed Lalani and Brad Baum noticed there was a subtext to much of what ... |
| - | Amolyt Pharma | “We are building on our team's established expertise in therapeutic peptides to deliver life-changing treatments to patients suffering from rare endocrine and metabolic diseases.” |
| - | Amolyt Pharma annonce la première administration d’AZP- 3601 | (14/10/2020) Amolyt Pharma annonce la première administration d’AZP-3601, analogue de la parathormone en développement dans l’hypoparathyroidie, dans son essai clinique de phase 1.
Lyon (France) et Newton, Massachusetts (Etats-Unis) – Am... |
